• 1
    Seeman E, Melton LJ III, O'Fallon WM, Riggs BL 1983 Risk factors for spinal osteoporosis in men. Am J Med 75:977983.
  • 2
    Melton LJ III, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL 1989 Epidemiology of vertebral fractures in women. Am J Epidemiol 129:10001011.
  • 3
    Slemenda CW, Hui SL, Longcope C, Wellman H, Johnston CC Jr 1990 Predictors of bone mass in perimenopausal women. A prospective study of clinical data using photon absorptiometry. Ann Intern Med 112:96101.
  • 4
    Felson DT, Zhang Y, Hannan MT, Anderson JJ 1993 Effects of weight and body mass index on bone mineral density in men and women: The Framingham study. J Bone Miner Res 8:567573.
  • 5
    Rubin CT, Lanyon LE 1985 Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 37:411417.
  • 6
    Hla MM, Davis JW, Ross PD, Wasnich RD, Yates AJ, Ravn P, Hosking DJ, McClung MR 1996 A multicenter study of the influence of fat and lean mass on bone mineral content: Evidence for differences in their relative influence at major fracture sites. Early Postmenopausal Intervention Cohort (EPIC) Study Group. Am J Clin Nutr 64:354360.
  • 7
    Schott AM, Cormier C, Hans D, Favier F, Hausherr E, Dargent-Molina P, Delmas PD, Ribot C, Sebert JL, Breart G, Meunier PJ 1998 How hip and whole-body bone mineral density predict hip fracture in elderly women: The EPIDOS Prospective Study. Osteoporos Int 8:247254.
  • 8
    Schindler AE, Ebert A, Friedrich E 1972 Conversion of androstenedione to estrone by human tissue. J Clin Endocrinol Metab 35:627630.
  • 9
    Grodin JM, Siiteri PK, MacDonald PC 1973 Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 36:207214.
  • 10
    Reid IR, Ames R, Evans MC, Sharpe S, Gamble G, France JT, Lim TM, Cundy TF 1992 Determinants of total body and regional bone mineral density in normal postmenopausal women-a key role for fat mass. J Clin Endocrinol Metab 75:4551.
  • 11
    Reid IR, Evans MC, Cooper GJ, Ames RW, Stapleton J 1993 Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol 265:E655E659.
  • 12
    Barret-Connor E, Kritz-Silverstein D 1996 Does hyperinsulinemia preserve bone? Diabetes Care 19:13881392.
  • 13
    Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425432.
  • 14
    Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J 1995 Identification and expression cloning of a leptin receptor, OB-R. Cell 83:12631271.
  • 15
    Thomas T, Burguera B, Melton LJ III, Atkinson EJ, O'Fallon WM, Riggs BL, Khosla S 2000 Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 49:12781284.
  • 16
    Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292295.
  • 17
    Wauters M, Considine RV, Van Gaal LF 2000 Human leptin: From an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 143:293311.
  • 18
    Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL 1999 Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140:16301638.
  • 19
    Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA 2001 Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16:14261433.
  • 20
    Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, Riggs BL, Turner RT 2001 Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142:35463553.
  • 21
    Holloway WR, Collier FM, Aitken CG, Malakellis M, Gough TJ, Myers DE, Collier GR, Nicholson GC 2000 Leptin inhibits osteoclast generation. J Bone Miner Res 15:S1;S174.
  • 22
    Gregoire Nyomba BL, Johnson M, Berard L, Murphy LJ 1999 Relationship between serum leptin and the insulin-like growth factor-I system in humans. Metabolism 48:840844.
  • 23
    Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100:197207.
  • 24
    Thomas T, de Vittoris R, David VN, Vico L, Lafage-Proust MH, Alexander C 2001 Leptin prevents disuse-induced bone loss in tail-suspended female rats. J Bone Miner Res 16:S1;S143.
  • 25
    Thomas T, Burguera B, Melton LJ III, Atkinson EJ, O'Fallon WM, Riggs BL, Khosla S 2001 Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 29:114120.
  • 26
    Goulding A, Taylor RW 1998 Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63:456458.
  • 27
    Pasco JA, Henry MJ, Kotowicz MA, Collier GR, Ball MJ, Ugoni AM, Nicholson GC 2001 Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 86:18841887.
  • 28
    Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S, Ozuru R, Sugishita T, Chihara K 2001 Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol (Oxf) 55:341347.
  • 29
    Blain H, Vuillemin A, Guillemin F, Durant R, Hanesse B, de Talance N, Doucet B, Jeandel C 2002 Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 87:10301035.
  • 30
    Rauch F, Blum WF, Klein K, Allolio B, Schonau E 1998 Does leptin have an effect on bone in adult women? Calcif Tissue Int 63:453455.
  • 31
    Odabasi E, Ozata M, Turan M, Bingol N, Yonem A, Cakir B, Kutlu M, Ozdemir IC 2000 Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 142:170173.
  • 32
    Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R 2001 Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 28:113117.
  • 33
    Ruhl CE, Everhart JE 2002 Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 17:18961903.
  • 34
    Blum M, Harris SS, Must A, Naumova EN, Phillips SM, Rand WM, Dawson-Hughes B 2003 Leptin, body composition and bone mineral density in premenopausal women. Calcif Tissue Int 73:2732.
  • 35
    Westvik J 1996 Radiological features in generalised lipodystrophy. Acta Paediatr 413(Suppl):4451.
  • 36
    Sato M, Takeda N, Sarui H, Takami R, Takami K, Hayashi M, Sasaki A, Kawachi S, Yoshino K, Yasuda K 2001 Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab 86:52735276.
  • 37
    Ormarsdottir S, Ljunggren O, Mallmin H, Olofsson H, Blum WF, Loof L 2001 Inverse relationship between circulating levels of leptin and bone mineral density in chronic liver disease. J Gastroenterol Hepatol 16:14091414.
  • 38
    Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K 1996 cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286289.
  • 39
    Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:7983.
  • 40
    Matsubara M, Maruoka S, Katayose S 2002 Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 147:173180.
  • 41
    Diez JJ, Iglesias P 2003 The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293300.
  • 42
    Yokota T, Meka CS, Medina KL, Igarashi H, Comp PC, Takahashi M, Nishida M, Oritani K, Miyagawa J, Funahashi T, Tomiyama Y, Matsuzawa Y, Kincade PW 2002 Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest 109:13031310.
  • 43
    Baecke JA, Burema J, Frijters JE 1982 A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936942.
  • 44
    World Health Organization Study Group on Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis 1994 Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis: Report of a World Health Organization Study Group, ed. 843. World Health Organization, Geneva, Switzerland.
  • 45
    Chrousos GP, Torpy DJ, Gold PW 1998 Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications. Ann Intern Med 129:229240.
  • 46
    Komesaroff PA, Esler MD, Sudhir K 1999 Estrogen supplementation attenuattes glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab 84:606610.
  • 47
    Heymsfield SB, Gallagher D, Poehlman ET, Wolper C, Nonas K, Nelson D, Wang ZM 1994 Menopausal changes in body composition and energy expenditure. Exp Gerontol 29:377389.
  • 48
    Räikkönen K, Matthews KA, Kuller LH, Reiber C, Bunker CH 1999 Anger, hostility, and visceral adipose tissue in healthy postmenopausal women. Metabolism 48:11461151.
  • 49
    Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, Patti ME, Klein SL, Weinstein RS, Scherer PE 2003 Sexual differentiation, pregnancy, calorie restriction and aging affect the adipocyte-specific secretory protein, adiponectin. Diabetes 52:268276.
  • 50
    Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 1999 Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 100:24732476.
  • 51
    Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305317.
  • 52
    Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS 1996 Role of leptin in fat regulation. Nature 380:677.
  • 53
    Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI 1997 Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100:270278.
  • 54
    Dunbar JC, Hu Y, Lu H 1997 Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46:20402043.
  • 55
    Jang M, Mistry A, Swick AG, Romsos DR 2000 Leptin rapidly inhibits hypothalamic neuropeptide Y secretion and stimulates corticotropin-releasing hormone secretion in adrenalectomized mice. J Nutr 130:28132820.
  • 56
    Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540543.
  • 57
    Mizuno A, Murakami T, Otani S, Kuwajima M, Shima K 1998 Leptin affects pancreatic endocrine functions through the sympathetic nervous system. Endocrinology 139:38633870.
  • 58
    Ahima RS, Flier JS 2000 Leptin. Annu Rev Physiol 62:413437.
  • 59
    Zhang Y, Matheny M, Zolotukhin S, Tumer N, Scarpace PJ 2002 Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: Influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim Biophys Acta 1584:115122.